BMY: Bristol-Myers Squibb Company Stocks News on April 3, 2025

Is Bristol Myers Squibb's High-Yielding Dividend Safe?

BMY

Motley Fool

19 hours ago

Is Bristol Myers Squibb's High-Yielding Dividend Safe?

CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo

BMY

Zacks

a day ago

CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

BMY

Zacks

2 days ago

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

Is Bristol-Myers Squibb (BMY) One of the Best Healthcare Stocks to Buy According to Billionaires?

BMY

Insider Monkey

2 days ago

Is Bristol-Myers Squibb (BMY) One of the Best Healthcare Stocks to Buy According to Billionaires?

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

BMY

Zacks

2 days ago

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Beat the S&P 500 With This Cash-Gushing Dividend Stock

BMY

Motley Fool

2 days ago

Beat the S&P 500 With This Cash-Gushing Dividend Stock

Bristol-Myers Squibb Company (BMY): Among the Best High Yield Stocks to Buy in April for Dividend Capture

BMY

Insider Monkey

2 days ago

Bristol-Myers Squibb Company (BMY): Among the Best High Yield Stocks to Buy in April for Dividend Capture

Jim Cramer on Bristol-Myers Squibb. Co (NYSE:BMY): They Should Have Known Better

BMY

Insider Monkey

5 days ago

Jim Cramer on Bristol-Myers Squibb. Co (NYSE:BMY): They Should Have Known Better

Why Bristol-Myers Squibb Co. (BMY) Went Up On Friday?

BMY

Insider Monkey

5 days ago

Why Bristol-Myers Squibb Co. (BMY) Went Up On Friday?

Bristol-Myers Squibb (NYSE:BMY) Sees Rising Interest in Sotyktu Despite 3% Share Price Dip

BMY

Simply Wall St.

5 days ago

Bristol-Myers Squibb (NYSE:BMY) Sees Rising Interest in Sotyktu Despite 3% Share Price Dip

BMY

MT Newswires

6 days ago

Bristol-Myers Squibb Says New Opdivo Formulation Recommended for Approval by EU Regulatory Panel

Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...

BMY

Business Wire

6 days ago

Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

BMY

Business Wire

6 days ago

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form

BMY

Yahoo Finance

7 days ago

Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form

Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates

BMY

Zacks

7 days ago

Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates

3 Deeply Discounted Dividend Stocks to Buy Today

BMY

Motley Fool

7 days ago

3 Deeply Discounted Dividend Stocks to Buy Today

Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts

BMY

Zacks

7 days ago

Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts

Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”

BMY

Insider Monkey

7 days ago

Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”

1 Large-Cap Stock on Our Watchlist and 2 to Brush Off

BMY

StockStory

8 days ago

1 Large-Cap Stock on Our Watchlist and 2 to Brush Off

Is Bristol-Myers Squibb (BMY) The Best Healthcare Dividend Stock to Invest in?

BMY

Insider Monkey

10 days ago

Is Bristol-Myers Squibb (BMY) The Best Healthcare Dividend Stock to Invest in?

8 key drug patents expiring soon — and what it means for the market

BMY

Quartz

10 days ago

8 key drug patents expiring soon — and what it means for the market

Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires?

BMY

Insider Monkey

11 days ago

Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires?

Bristol-Myers Squibb Company (BMY): Among Incredibly Cheap Dividend Stock to Buy Now

BMY

Insider Monkey

12 days ago

Bristol-Myers Squibb Company (BMY): Among Incredibly Cheap Dividend Stock to Buy Now

Is Bristol-Myers Squibb Company (BMY) The Best Undervalued Stock to Buy According to Billionaires?

BMY

Insider Monkey

14 days ago

Is Bristol-Myers Squibb Company (BMY) The Best Undervalued Stock to Buy According to Billionaires?

2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

BMY

Motley Fool

14 days ago

2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note

BMY

Zacks

14 days ago

Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note

Is Bristol-Myers Squibb (BMY) the Most Undervalued Biotech Stock to Invest In?

BMY

Insider Monkey

15 days ago

Is Bristol-Myers Squibb (BMY) the Most Undervalued Biotech Stock to Invest In?

Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination

BMY

TipRanks

15 days ago

Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination

Bristol-Myers Squibb Company (BMY): A Bull Case Theory

BMY

Insider Monkey

16 days ago

Bristol-Myers Squibb Company (BMY): A Bull Case Theory

EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy

BMY

Pharmaceutical Technology

17 days ago

EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy

Why Bristol-Myers Squibb Company (BMY) Went Down On Friday?

BMY

Insider Monkey

19 days ago

Why Bristol-Myers Squibb Company (BMY) Went Down On Friday?

Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment

BMY

Simply Wall St.

19 days ago

Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment

BMY

MT Newswires

20 days ago

Bristol-Myers Squibb Says EU Approves Breyanzi for Relapsed, Refractory Follicular Lymphoma

$Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma$

BMY

Business Wire

20 days ago

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.

BMY

The Wall Street Journal

20 days ago

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.

BMY

Zacks

20 days ago

Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts

Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?

BMY

Zacks

21 days ago

Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?

Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025

BMY

Business Wire

21 days ago

Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds?

BMY

Insider Monkey

21 days ago

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds?

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

BMY

Zacks

22 days ago

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

BMS to acquire longtime cell therapy partner 2seventy bio for $286m

BMY

Pharmaceutical Technology

22 days ago

BMS to acquire longtime cell therapy partner 2seventy bio for $286m

TSVT Up on Acquisition Agreement With BMY for $286 Million

BMY

Zacks

22 days ago

TSVT Up on Acquisition Agreement With BMY for $286 Million

BMY

MT Newswires

23 days ago

Top Premarket Gainers

2seventy bio, Bluebird’s cell therapy spinout, sells to Bristol Myers for less than $300M

BMY

BioPharma Dive

23 days ago

2seventy bio, Bluebird’s cell therapy spinout, sells to Bristol Myers for less than $300M

BMY

Argus Research

23 days ago

Technical Assessment: Neutral in the Intermediate-Term

BMY

MT Newswires

23 days ago

2seventy Bio to be Acquired by Bristol Myers Squibb

BMY

Morningstar Research

23 days ago

Analyst Report: Bristol-Myers Squibb Company

Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out

BMY

Investor's Business Daily

23 days ago

Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out

Bristol Myers Stock Gains 9.2% in a Month: Should You Buy Now or Wait?

BMY

Zacks

23 days ago

Bristol Myers Stock Gains 9.2% in a Month: Should You Buy Now or Wait?

Bristol-Myers Squibb Company (BMY): One of the Best Performing Dividend Stocks to Buy Now

BMY

Insider Monkey

24 days ago

Bristol-Myers Squibb Company (BMY): One of the Best Performing Dividend Stocks to Buy Now

EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC

BMY

Zacks

24 days ago

EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC

EC approves BMS’ Opdivo and Yervoy combo for HCC

BMY

Pharmaceutical Technology

24 days ago

EC approves BMS’ Opdivo and Yervoy combo for HCC

Is Bristol-Myers Squibb Company (BMY) The Best Cheap Dividend Stock To Buy Right Now?

BMY

Insider Monkey

25 days ago

Is Bristol-Myers Squibb Company (BMY) The Best Cheap Dividend Stock To Buy Right Now?

Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis

BMY

Business Wire

a month ago

Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis

Jim Cramer Highlights ‘Multi-Billionaire Dollar’ Catalyst for Bristol-Myers Squibb Company (BMY)

BMY

Insider Monkey

a month ago

Jim Cramer Highlights ‘Multi-Billionaire Dollar’ Catalyst for Bristol-Myers Squibb Company (BMY)

BMY

MT Newswires

a month ago

Bristol-Myers Squibb Says Opdivo With Yervoy Approved in EU to Treat Liver Cancer

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma

BMY

Business Wire

a month ago

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma

Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note

BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note

Is Bristol-Myers Squibb Company (BMY) the Best Dividend Stock to Buy According to Billionaires?

BMY

Insider Monkey

a month ago

Is Bristol-Myers Squibb Company (BMY) the Best Dividend Stock to Buy According to Billionaires?

Bristol-Myers Squibb (NYSE:BMY) Declares US$0.62 Dividend On Common Stock And US$0.50 On Preferred Stock

BMY

Simply Wall St.

a month ago

Bristol-Myers Squibb (NYSE:BMY) Declares US$0.62 Dividend On Common Stock And US$0.50 On Preferred Stock

BMY

MT Newswires

a month ago

Evotec Receives $20 Million Research Payment From Bristol Myers Squibb

Bristol-Myers Squibb Company (BMY): Among the Best S&P 500 Dividend Stocks to Buy Now

BMY

Insider Monkey

a month ago

Bristol-Myers Squibb Company (BMY): Among the Best S&P 500 Dividend Stocks to Buy Now

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

BMY

StockStory

a month ago

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

BMY

Business Wire

a month ago

Bristol Myers Squibb Announces Dividend

Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know

BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know

BMY

MT Newswires

a month ago

HSBC Adjusts Price Target on Bristol-Myers Squibb to $56 From $58, Keeps Hold Rating

Drug Stocks Are the New Safe Bet in a Shaky Market

BMY

The Wall Street Journal

a month ago

Drug Stocks Are the New Safe Bet in a Shaky Market

Praxis hits trial setback; Bristol Myers lays off staff in New Jersey

BMY

BioPharma Dive

a month ago

Praxis hits trial setback; Bristol Myers lays off staff in New Jersey

Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q4 Earnings?

BMY

StockStory

a month ago

Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q4 Earnings?

Bristol-Myers Squibb Company (BMY): Top Stock to Buy from Dividend Stock Portfolio For Income

BMY

Insider Monkey

a month ago

Bristol-Myers Squibb Company (BMY): Top Stock to Buy from Dividend Stock Portfolio For Income

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

BMY

Zacks

a month ago

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

Got $200? 2 Healthcare Stocks to Buy and Hold Forever

BMY

Motley Fool

a month ago

Got $200? 2 Healthcare Stocks to Buy and Hold Forever

Why Bristol-Myers Squibb Co (BMY) Went Up On Monday?

BMY

Insider Monkey

a month ago

Why Bristol-Myers Squibb Co (BMY) Went Up On Monday?

Bristol Myers Squibb to Participate in Upcoming Investor Conferences

BMY

Business Wire

a month ago

Bristol Myers Squibb to Participate in Upcoming Investor Conferences

FDA accepts BMS’ Opdivo-Yervoy combo sBLA for colorectal cancer

BMY

Pharmaceutical Technology

a month ago

FDA accepts BMS’ Opdivo-Yervoy combo sBLA for colorectal cancer

BMY

MT Newswires

a month ago

Bristol-Myers Squibb Colorectal Drug Accepted for Priority Review

U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Supplemental Biologics License Application for Opdivo® Plus Yervoy® for Patients with Unresectable or Metastatic Microsatellite Instability-High or Mismatch Repair Deficient...

BMY

Business Wire

a month ago

U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Supplemental Biologics License Application for Opdivo® Plus Yervoy® for Patients with Unresectable or Metastatic Microsatellite Instability-High or Mismatch Repair Deficient...

BMY

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 02/24/2025

Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus

BMY

Zacks

a month ago

Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus

BMY

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 02/20/2025

BMY

Clinical Trials Arena

a month ago

BMS’ Opdivo plus chemotherapy shows OS benefit in Phase III NSCLC study

Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer

BMY

Benzinga

a month ago

Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer

BMY

MT Newswires

a month ago

Amneal Pharmaceuticals Launching Mesalamine, Gets US FDA Approval for Lenalidomide

BMY

MT Newswires

a month ago

Bristol-Myers Squibb's Lung Cancer Drug Shows Significant Increase in Patients' Overall Survival

Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer

BMY

Business Wire

a month ago

Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer

Bristol Myers announces new five-year results from POETYK PSO trial

BMY

TipRanks

a month ago

Bristol Myers announces new five-year results from POETYK PSO trial

BMY

MT Newswires

a month ago

Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $54 From $52, Maintains Neutral Rating

BMY

Clinical Trials Arena

a month ago

Bristol Myers Squibb’s Sotyktu shows consistent safety profile in psoriasis trial

Why Bristol-Myers Squibb (BMY) Is Among the Best Drug Stocks to Buy Now

BMY

Insider Monkey

a month ago

Why Bristol-Myers Squibb (BMY) Is Among the Best Drug Stocks to Buy Now

New Five-Year Sotyktu (deucravacitinib) Data Show Consistent Safety and Durable Response Rates in Moderate-to-Severe Plaque Psoriasis

BMY

Business Wire

2 months ago

New Five-Year Sotyktu (deucravacitinib) Data Show Consistent Safety and Durable Response Rates in Moderate-to-Severe Plaque Psoriasis

BMY

GuruFocus.com

2 months ago

BioArctic AB (BRCTF) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Profitability ...

BMY

MT Newswires

2 months ago

Bristol-Myers Squibb's Melanoma Treatment Fails to Meet Primary Endpoint in Phase 3 Adjuvant Trial

BMY

Business Wire

2 months ago

Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial

Bristol-Myers Squibb Company (BMY) – Jim Cramer: “No, No, You Don’t Hold”

BMY

Insider Monkey

2 months ago

Bristol-Myers Squibb Company (BMY) – Jim Cramer: “No, No, You Don’t Hold”

Shareholders in Bristol-Myers Squibb (NYSE:BMY) have lost 7.2%, as stock drops 5.4% this past week

BMY

Simply Wall St.

2 months ago

Shareholders in Bristol-Myers Squibb (NYSE:BMY) have lost 7.2%, as stock drops 5.4% this past week

BMY Down 7% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?

BMY

Zacks

2 months ago

BMY Down 7% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?

Jim Cramer on Bristol-Myers (BMY): Cobenfy’s Success vs. Patent Headwinds

BMY

Insider Monkey

2 months ago

Jim Cramer on Bristol-Myers (BMY): Cobenfy’s Success vs. Patent Headwinds

BMS’ Phase II trial of CAR T cell therapy meets primary endpoint

BMY

Clinical Trials Arena

2 months ago

BMS’ Phase II trial of CAR T cell therapy meets primary endpoint

The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.

BMY

The Wall Street Journal

2 months ago

The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.

BMY

MT Newswires

2 months ago

Latest Bristol-Myers Squibb Company (BMY) News on April 3, 2025

Share on Social Networks: